Vimarsana
Biggest News Aggregation in the World

Page 7 - Arrayit Corporation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arrayit Corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arrayit Corporation Today - Breaking & Trending Today

BUSTED: Top medical fraud and illegal health care schemes of 2022 - Vimarsana News

BUSTED: Top medical fraud and illegal health care schemes of 2022

It would be wonderful if Big Pharma actually produced effective medications and vaccinations that did not bring with them a laundry list of horrific side effects and long term health detriment, [...]

California coronavirus updates: Flu season could be headed to the U.S. early - Vimarsana News

California coronavirus updates: Flu season could be headed to the U.S. early

After virtually disappearing for two years as the COVID-19 pandemic raged, influenza seems to be poised to stage a comeback this year in the U.S., NPR reports.

California coronavirus updates: DOJ charges 48 people in COVID-19 pandemic funds scheme - Vimarsana News

California coronavirus updates: DOJ charges 48 people in COVID-19 pandemic funds scheme

The Department of Justice has charged 48 people in what prosecutors have called a scheme to take advantage of the COVID-19 pandemic to fraud the U.S. government of $250 million.

Arrayit President Found Guilty of Fraud and EKRA Violations - Vimarsana News

Arrayit President Found Guilty of Fraud and EKRA Violations

Mark Schena, President of Arrayit Corporation, has been found guilty for violations of Eliminating Kickbacks in Recovery Act EKRA, healthcare fraud, wire fraud, securities fraud. Superseding indictment issued against him for promoting Arrayit with false statements.

California coronavirus updates: FDA concedes delays in response to baby formula shortages - Vimarsana News

California coronavirus updates: FDA concedes delays in response to baby formula shortages

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.